A recent study conducted on 537 patients with transfusion-dependent beta-thalassemia in Cyprus revealed that male gender and milder beta-globin gene (HBB) genotype were significantly associated with poorer outcomes [28]. The gene discussed is HBB; the disease is Beta-thalassemia.